Wikidata

(Q80250299)

English

Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study

scientific article published on 01 September 2006

In more languages

Statements

title
Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16968575
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16968575%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q80250299&oldid=1529047283"